Group 1: Market Outlook and Strategy - The domestic capital expenditure growth is expected to slow down in 2026, but structural opportunities remain, prompting the company to actively explore domestic market expansion and seize capacity expansion opportunities in niche markets [2][3] - In international markets, regions such as Southeast Asia, South Asia, Africa, and the Middle East are experiencing rapid increases in per capita beverage consumption, which the company aims to leverage for expanding international orders and improving order quality [2][3] Group 2: Production Capacity and Operations - The company currently has sufficient orders, and after the completion of factory expansion projects, it plans to enhance assembly efficiency through scientific production scheduling and lean manufacturing to meet delivery demands [3][4] - As of the first half of 2025, the revenue from the company's OEM (Original Equipment Manufacturer) business accounted for 6.05% of total revenue, primarily involving the production of PET preforms, bottled beverages, and daily chemical products [3] Group 3: Currency and Risk Management - The majority of overseas orders are settled in USD, with RMB and other currencies used for regional transactions; the company monitors exchange rate fluctuations and may engage in foreign exchange hedging to manage risks [3] - The payment performance of major clients in India is currently good, with no significant default risks reported [3] Group 4: Technology and Innovation - There is no straightforward substitution logic between dry and wet sterilization processes; the choice of technology depends on the product characteristics and production needs of clients [4] - The initial investment for dry sterilization lines is slightly higher than that for wet sterilization lines, but cost comparisons are highly dependent on customized client requirements [4]
达 意 隆(002209) - 2026年1月28日-1月30日投资者关系活动记录表